NICE Technology Appraisal

  Level 1A, City Tower
Piccadilly Plaza
M1 4BTTel: 0845 003 7780
Fax: 0845 003 7784


Technology Appraisal Advisory Committee


Tuesday 28 February 2017



Dear consultees and commentators,


I am writing to inform you that the public registration facility to observe the committee meeting for everolimus, lutetium-177 DOTATATE and sunitinib for treating unresectable or metastatic neuroendocrine tumours with disease progression will open on Tuesday 31 January 2017 on the NICE website.  


If you would like to register for this committee meeting, please do so via the following web page: . Registration for this meeting will close on Tuesday 14 February 2017 at 5pm. Please note we may be unable to accept late requests to observe this meeting.


As a public observer, you will be able to listen to the business of the meeting, except where confidential information is being discussed, however, you will not be able to:

·         participate in committee discussions 

·         ask questions, take part in voting or put your views to members of the committee 


For further information about meetings in public please refer to the following document: Common questions and answers about meetings in public


Should you have any queries regarding observing this meeting, please contact the Meetings in Public Coordinator, Jonathan Littler, [email protected]


Kind regards



Kate Moore 
Technology Appraisals Project Manager – Committee D